This PDF is the current document as it appeared on Public Inspection on 01/08/2016 at 08:45 am.
Notice of registration.
Alltech Associates, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Alltech Associates, Inc. registration as a manufacturer of those controlled substances.End Preamble Start Supplemental Information
By notice dated August 10, 2015, and published in the Federal Register on August 18, 2015, 80 FR 50041, Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, Illinois 60015 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice.
The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Alltech Associates, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances:
|4-Methylaminorex (cis isomer) (1590)||I|
|Gamma Hydroxybutyric Acid (2010)||I|
|Lysergic acid diethylamide (7315)||I|
|2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (7348)||I|
|Start Printed Page 1209|
|2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) (7509)||I|
|2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) (7517)||I|
|2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) (7518)||I|
|2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4) (7532)||I|
|Meperidine intermediate-B (9233)||II|
The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories and for distribution to its customers.Start Signature
Dated: January 4, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-00216 Filed 1-8-16; 8:45 am]
BILLING CODE 4410-09-P